swot analysis of pharmaceutical marketing focusing on international business

WELCOME

SWOT Analysis of Pharmaceutical Marketing in

Bangladesh Focusing on International Business

PHARMACEUTICAL MARKETING 3

PRESENTED BY NAME: REGISTRATION NO:

PROTIK BISWAS 12103040

PRIYANKA FLORINA KARMOKAR 12103050

NAJMUL ISLAM 12103056

SANJIDA BINTE NUR NISHU 12103042

KOUSIK HALDER 12103001

AHASANUL SADIK 12103019

ANIK KUMER TARAFDER 12103027

4

Objectives: An overview of pharmaceutical sector in

Bangladesh.

The pharmaceutical export scenario of

Bangladesh.

SWOT analysis of pharmaceutical

marketing in Bangladesh focusing on

international business.

Challenges & recommendations for

exporting pharmaceutical products.PHARMACEUTICAL MARKETING


An Overview of Pharmaceutical Sector in Bangladesh

One of the most technologically advanced sector.

According to the information of the Directorate General of

Drug Administration of Bangladesh (DGDA):

270 -Allopathic drug manufacturing companies .

Country’s demand

97%-Domestic

3%-Imported


Predominantly a branded generic marketplace.

Produce more than 500 types of medicines locally,

around 5,300 brands

over 8,000 formulations.

According to IMS Report of 4th quarter of 2013

Total Market: approximately Tk 9441 (Cr)

Annual Growth: 8.12%

An Overview of Pharmaceutical Sector in Bangladesh


18.70%9.80%8.60%

5.30%5.00%

52.60%

Local Market Share in Medicine MarketingSource: The Bangladesh Pharmaceutical

Index 2013(1st quarter)

SQUARE

INCEPTA PHARMA

BEXIMCO

OPSONIN PHARMA

RENATA

OTHERS


Export Scenario of Pharmaceuticals from Bangladesh

Exporting Companies=49

Exports Destinations =104

countries.

Covering all major therapeutic

classes & dosage forms.

Comparable to any international

standard.

Huge value addition.


2008-09 2009-10 2010-11 2011-12 2012-130

10

20

30

40

50

60

36.19 40.97 44.27 48.2559.82

Pharmaceutical Exports from Bangladesh (in Millions of Dollar)

FY 2008/09 to FY 12/13Source: Export Promotion Bureau (EPB)


19.04%

16.34%

14.00%10.31%

4.03%3.47%

32.81%

Market share in Exporting at 2013Total Export Value in BDT =6,199,276,557.63

Source: Export Promotion Bureau(EPB)

BEXIMCONOVARTISSQUAREINCEPTAACMERENATAOTHERS


Pharmaceutical Export from Bangladesh after 2016


What if Patent Right is enforced?

PRODUCTON COST INDIA & CHINA

EXPORT MARKET EXISTENSE IN GLOBAL MARKET


SWOT Analysis of Pharmaceutical Marketing in Bangladesh Focusing on International Business


Strengths:

Producing world-class products.

Products acceptable as ‘Quality

Products’.

Wide range of products.

Competitive Price.

Strong brand image.


Manpower at minimum cost.

Supportive government policy.

Do not have to comply IPR until

2016.

Backward linkage support.

Large domestic market.

The largest sector in terms of capital

investment.


Weaknesses:Lack of research activities.

Lack of bioequivalence test facilities.

Import dependence on active ingredients.

Lack of future planning to expand export.


Opportunities:

API Park

Joint venture investment opportunities.

Research and development activities

may be initiated with external support.

Compulsory licensing & contract

manufacturing.


Extending of Patent Right.

Pharmaceutical marketing is going to

hit worldwide 1 trillion dollar.

Government-to-Government (G2G)

agreement.

The removal of patent right worldwide

from some fast moving drug products.

Opportunities:


THREATS:

Threats: Very competitive & uneven market.

The emergence of a patent regime in 2016.

India & China are big challenge.

Unfavorable regulations for pharmaceutical export.

Lack of co-operation.

Insufficient activities DGDA.

Negative country image.


CHALLENGES & RECOMMENDATIONS FOR EXPORTING PHARMACEUTICAL PRODUCTS

API/Raw Material Production Plant

Bioequivalence Test Facility

Modern Drug Testing Laboratory

Custom Harassment in Sending Drug Sample

The regulatory authorities of Bangladesh

Regulated Markets

Export should be emphasized to LDCs

Establishing Export cell by the govt./private

Consultancy firms

21

References: Primary Data:

PHARMACEUTICAL MARKETING

Name of executives Designation Name of Company

Sk.raquibur Rahman Manager,International Marketing

Advanced Chemical Industries Limited(ACI)

Mohammad Abul Basher Howlader

Marketing Manager Advanced Chemical Industries Limited(ACI)

Ashraful Islam Senior Executive,International

Marketing

Incepta Pharmaceuticals Ltd.

Shaker Hussain Officer,International Business

Radiant Pharmaceuticals(licensee of F.Hoffmann-La Roche

Ltd


Secondary Data:

References:

Media Source

Magazines Medipharm

News Paper The Daily Star

Reports 1. Bangladesh Pharmaceuticals & Healthcare Report Q3 2014

2. Pharmaceutical Sector of Bangladesh: Prospects and Challenges

3. Pharmaceutical Opportunities in Bangladesh

Different Website http://www.dgda.gov.bd/http://www.espicom.com/bangladesh-pharmaceutical-market.html Etc.


ANY QUESTIONS?


THANK YOU !